A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of a Single Subcutaneous Dose of Tralokinumab When Delivered as a 2 mL Injection at Different Flow Rates to Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2018
Price : $35 *
At a glance
- Drugs Tralokinumab (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors MedImmune
- 30 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Mar 2014 New trial record